Is Ellume listed on the ASX?

Why is it so hard to find the healthcare company Ellume on the ASX? That's because it's a private company. Here's what we know.

A sign saying private on a glass window

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ellume has been a company on every investors' lips over the past couple of months. The Brisbane-based medical company has been at the vanguard of Australia's contribution to fighting the coronavirus pandemic.

The company has pioneered an 'at-home' test for COVID-19. Patients can use this test to get an accurate result within 15 minutes without seeing a doctor or getting the test analysed at a lab.

You can look, but you can't own…

So, very understandably, many ASX investors have been looking for ways to invest in Ellume on the ASX. Some are even going as far as searching for an Ellume ticker code. Unfortunately, those efforts have been and will continue to be, fruitless. See, Ellume is a private company, with its shares unavailable for public investors to trade and invest in.

According to a report in the Australian Financial Review (AFR) this week, Ellume actually was considering an ASX-listing through an initial public offering (IPO) around 2½ years ago. The company reportedly even went as far as hiring PAC Partners to assist it with a pre-IPO capital raise and a subsequent listing on the ASX. But alas for its would-be shareholders, this process didn't end up eventuating.

As a private company, Ellume does have shares (84 million according to the AFR report). They are held by a small group of founders, employees and investors at Ellume though. The AFR tells us that Ellume chair and investor Paul Darrouzet holds a quarter of Ellume's shares. Dr Sean Parsons, Ellume's founder and managing director, owns another 14 million.

The rest of Ellume's board also reportedly has ownership stakes. Options and performance shares are often part of board members' salaries as well.

How much are Ellume's shares worth?

It's hard to say exactly how much Ellume and its shares are worth, seeing as the data is not in the public arena. But guesses in the billions are probably not wild. That's because (as we reported at the time) Ellume has recently signed a massive US$250 million contract with the US government to supply 8.5 million testing kits. The deal also involves Ellume building a factory on US soil to meet demand.

Can you invest in Ellume on the ASX?

As we've discussed, you can't directly invest in Ellume on the ASX. However, there are a few other ASX-listed companies that operate in the same space as Ellume. These include Atomo Diagnostics Ltd (ASX: AT1) and Anteotech Ltd (ASX: ADO).

Indeed, Anteotech shares spiked 95% last week on news that it was continuing to work with Ellume in providing some of the technology that goes into the testing.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 200 shares could rise 20% to 35%

These shares are being tipped to deliver market-beating returns by analysts.

Read more »

Keyboard button with the word sell on it.
Broker Notes

8 ASX All Ords stocks downgraded to sell ratings

Find out which shares are out of favour with the experts.

Read more »

Woman smiling whilst shopping in a clothing store.
Dividend Investing

Why this quality ASX 300 dividend stock is tipped to surge 54%

A leading fund manager forecasts significant outperformance from this quality ASX 300 dividend stock.

Read more »

A group of businesspeople clapping.
Broker Notes

Bell Potter names more of the best ASX 200 stocks to buy in June

These stocks could be best buys this month according to the broker.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Market News

Why Clarity, Coronado Global, Iperionx, and Lynas shares are roaring higher today

These shares are having a strong session on Thursday. Why are investors buying them?

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Opinions

The ASX 200 is approaching its all-time high. Here's why I'm not buying shares

I'm not seeing what the broader market is.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Qantas, Resimac, Tyro, and Soul Patts shares are falling today

These shares are having a tough session today. But why?

Read more »

Happy coal miner.
Share Gainers

Up 75% this week, why is this ASX All Ords stock rocketing again today?

Investors are piling into this ASX 300 stock on Wednesday. But why?

Read more »